Abstract:BACKGROUND: Hypermenorrhea is characterized by excessive menstrual bleeding that causes severe anemia and interferes with everyday life. This condition can restrict women's social activities and decrease their quality of life. Microwave endometrial ablation (MEA) using a 2.45-GHz energy source is a minimally invasive alternative to conventional hysterectomy for treating hypermenorrhea that is resistant to conservative treatment, triggered by systemic disease or medications, or caused by uterine myomas and fibrosis. The popularity of MEA has increased worldwide. Although MEA can safely and effectively treat submucous myomas, some patients may still experience recurrent hypermenorrhea postoperatively and may require additional treatment.AIM: To investigate the efficacy of MEA combined with transcervical resection (TCR).METHODS: Participants underwent cervical and endometrial evaluations. Magnetic resonance imaging and hysteroscopy were performed to evaluate the size and location of the myomas. TCR was performed before MEA using a hystero-resectoscope. MEA was performed using transabdominal ultrasound. The variables included operation time, number of ablation cycles, length of hospital stay, and visual analog scale cores for hypermenorrhea, dysmenorrhea, and treatment satisfaction at 3 and 6 mo postoperatively. The postoperative incidence of amenorrhea, changes in hemoglobin concentrations, and MEA-related complications were evaluated.RESULTS: A total of 34 women underwent a combination of MEA and TCR during the study period. Two patients were excluded from the study as their histopathological tests identified uterine malignancies (uterine sarcoma and endometrial cancer). The 32 eligible women (6 nulliparous, 26 multiparous) had a mean age of 45.2 ± 4.3 years (range: 36-52 years). Patients reported very severe hypermenorrhea (10/10 points on the visual analog scale) before the procedure. However, after the procedure, the hypermenorrhea scores decreased to 1.2 ± 1.3 and 0.9 ± 1.3 at 3 and 6 mo, respectively (P < 0.001). The mean follow-up duration was 33.8 ± 16.8 mo. Although 10 women (31.3%) developed amenorrhea during this period, none experienced a recurrence of hypermenorrhea. No surgical complications were observed.CONCLUSION: Reducing the size of uterine myomas by combining MEA and TCR can safely and effectively treat hypermenorrhea in patients with submucous myomas.

Hysteroscopic electrocision for treatment of 52 cases with submucosal hysteromyoma

[Evaluation of a Self-Defined Classification of Uterine Submucous Myomas for Guiding Transcervical Hysteroscopic Electric Resection].

Hysteroscopic septum resection of complete septate uterus with cervical duplication, sparing the double cervix in patients with recurrent spontaneous abortions or infertility.

Evaluation of the Efficacy and Effectiveness of Hysteroscopic Electroresection in the Treatment of Submucosal Uterine Fibroids

[Clinical application of hysteroscopic electroresection in 775 cases]

[Transcervical Resection of Myoma in Treatment of Hysteromyoma, Experience in 962 X\cases].

Feasibility of a New System of Classification of Submucous Myomas: a Multicenter Study.

[Clinical Analysis of Metzenbaum Scissors in Transcervical Incision of a Complete Septate Uterus].

Clinical analysis of endoscopic resection for submucosal tumors in the esophagogastric junction

Hysteroscopic Shaving System for the Treatment of Uterine Submucous Leiomyoma

[Evaluation of results in transcervical hysteroscopic myoma resection]

[Endoscopic treatment of uterine myoma]

Comparative analysis of the clinical efficacy and reproductive outcomes of the hysteroscopic tissue removal system (MyoSure) and hysteroscopic electroresection in the treatment of benign intrauterine lesions

Effectiveness of microwave endometrial ablation combined with hysteroscopic transcervical resection in treating submucous uterine myomas

Comparison of ultrasound-guided high-intensity focused ultrasound ablation and hysteroscopic myomectomy for submucosal fibroids: a retrospective study

Hysteroscopic endomyometrial resection

[Clinical Study of Hysteroscopical Electroresection of FIGO Type 3 Myoma].

Follow-up study on the effectiveness of transcervical myoma resection (TCRM)

Two-Step Office-Based Hysteroscopic Operation for Submucosal Myoma

Clinical Study on Climacteric Dysfunctional Uterine Bleeding Treated with RevoLix 2 Micron Continuous Wave Laser Vaporesection and Hysteroscopic Endometrial Electroresection

Hysteroscopic myomectomy: a comprehensive review of surgical techniques